Bloomberg Law Launches Pharma Law Hub
Developed in response to customer input, the new Pharmaceutical Law & Practice page combines core topics, emerging issues, and data-infused content, along with tailored instructions on how to use
- Over 90 industry-specific Practical Guidance documents, including new Practical Guidance pages on FDA Compliance and Pharma Transactions.
- The In-House Pharma Toolkit, a resource for the whole legal department that includes pharma-specific content on key topics like Privacy, Data Security, M&A, Commercial Transactions and ESG, and tailored instructions on how to use
Bloomberg Law's tools for pharma lawyers. - Links to Bloomberg Law resources including Health Care Fraud Analytics, Dockets, Transactional Precedent Search, Deal Analytics, and Global Patent Search.
- A new 2024 edition of the book Pharmaceutical Patent Law.
Along with the new resource page,
The report includes analyses, which assess a variety of topics in the areas of litigation, transactions, and compliance through the legal lens of the pharmaceutical industry lawyer.
"
To download the new report, Focus on Pharma: Emerging Trends for Pharmaceutical Industry Lawyers, visit https://aboutblaw.com/bf0s.
About
View original content to download multimedia:https://www.prnewswire.com/news-releases/bloomberg-law-launches-pharma-law-hub-302281781.html
SOURCE
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 2026 World Internet Conference Digital Silk Road Development Forum Opens in Xi'an, Shaanxi Province
- Bitcoin Price Prediction: Macro Volatility Pushes Crypto Capital Toward AlphaPepe’s Product-Backed Presale
- Why Consumers Are Exploring PureHealth Research Optimal Health Supplements for Everyday Wellness
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share